NCT06542913

Brief Summary

a prospective cohort study comparing outcomes of left lobe and right lobe adult living donor liver transplantation

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Sep 2024

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 3, 2024

Completed
4 days until next milestone

First Posted

Study publicly available on registry

August 7, 2024

Completed
1 month until next milestone

Study Start

First participant enrolled

September 15, 2024

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 15, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 15, 2026

Completed
Last Updated

August 7, 2024

Status Verified

August 1, 2024

Enrollment Period

1.7 years

First QC Date

August 3, 2024

Last Update Submit

August 3, 2024

Conditions

Liver Transplant; Complications

Outcome Measures

Primary Outcomes (1)

  • small for size syndrome

    small for size syndrome

    1 year

Secondary Outcomes (1)

  • other complications after LDLT

    1 year

Study Arms (2)

right lobe

cases underwent LDLT for right lobe with borderline GRWR

left lobe

cases underwent LDLT for left lobe with borderline GRWR

Eligibility Criteria

Age16 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

patients presented to our center for LDLT

You may qualify if:

  • GRWR below 1

You may not qualify if:

  • patients with renal impairment portal vein thrombosis vascular complications

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Central Study Contacts

Ibrahim Essam, M.Sc. MRCS

CONTACT

00201001805340ibrahim.essam@med.asu.edu.eg

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 3, 2024

First Posted

August 7, 2024

Study Start

September 15, 2024

Primary Completion

June 15, 2026

Study Completion

June 15, 2026

Last Updated

August 7, 2024

Record last verified: 2024-08